Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Use for Subclassification and Genotyping of Lung Non-Small-Cell Carcinoma. Issue 8 (August 2018)

• Record Type: Journal Article
• Authors: Raad, Samih; Hanna, Nasser; Jalal, Shadia; Bendaly, Edmond; Zhang, Chen; Nuguru, Shashank; Oueini, Houssam; Diab, Khalil
• Is Part Of: Southern medical journal. Volume 111:Issue 8(2018)
• Publication Date: 2018-08
• Subjects: adenocarcinoma -- endobronchial ultrasound-guided fine needle aspiration -- endobronchial ultrasonography -- lung cancer, non-small-cell lung cancer; Medicine -- Periodicals; 610.5
• DOI: 10.14423/SMJ.0000000000000846
• Languages: English
• ISSNs: 0038-4348

Abstract

Abstract : Objectives: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the primary method for the diagnosis and staging of lung cancer. The purpose of this study was to assess the yield of EBUS-TBNA in the subtyping and genotyping of lung adenocarcinoma. Methods: Sixty-nine patients at Indiana University Hospital and Sidney and Lois Eskenazi Hospital with possible or confirmed lung adenocarcinoma underwent EBUS-TBNA using a 21-gauge Olympus needle without suction. Samples were sent for molecular testing after rapid onsite specimen evaluation. A total of 6 to 10 passes were placed in a cell block. Results: Sixty-nine samples from patients with non-small-cell lung cancer were sent for molecular testing for epidermal growth factor receptor. Results were obtained in all of the patients. Mutations were found in three patients (4.3%). Fifty-eight samples were sent for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (100% yield), 10 of which had mutations (17.2%). Fifty-one samples were sent for proto-oncogene tyrosine-protein kinase ROS testing (1 [7.8%] mutant). Tissue samples were inadequate in three patients (94.1% yield). Sixty-three samples were sent for anaplastic lymphoma receptor tyrosine kinase testing (3 [4.8%] mutant, 6 [9.5%] inadequate, 90.5% yield). Conclusions: EBUS-TBNA with a 21-gauge needle is appropriate for the analysis of multiple mutations and the genotyping of lung adenocarcinoma. Abstract : The treatment of non-small-cell lung cancer, especially lung adenocarcinoma, is becoming dependent increasingly on individualized characteristics of the tumor. These characteristics include an increasing list of multiple driver mutations that are used to guide targeted therapy. This article discusses the role and yield of endobronchial ultrasound-guided transbronchial needle aspiration in the analysis of these mutations.